While "interesting," the "subgroups with 'significant benefit' don't necessarily make sense," said late-breaking clinical trial session discussant Larry Allen, MD, MHS, of the University of Colorado in Aurora.
CU Anschutz
CU Medicine Building
13199 East Montview Boulevard
Suite 300
Aurora, CO 80045